| Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study H Gacaferi, GS Collaborative, COVIDSurg Collaborative Anaesthesia 76 (6), 2021 | 540* | 2021 |
| Circulating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with … S Salvi, V Casadio, V Conteduca, SL Burgio, C Menna, E Bianchi, L Rossi, ... British journal of cancer 112 (10), 1717-1724, 2015 | 143 | 2015 |
| Early outcome prediction on 18F-fluorocholine PET/CT in metastatic castration-resistant prostate cancer patients treated with abiraterone U De Giorgi, P Caroli, SL Burgio, C Menna, V Conteduca, E Bianchi, ... Oncotarget 5 (23), 12448, 2014 | 104 | 2014 |
| SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study. C COVIDSurg, C GlobalSurg Anaesthesia 77 (1), 28-39, 2022 | 101 | 2022 |
| 18F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide U De Giorgi, P Caroli, E Scarpi, V Conteduca, SL Burgio, C Menna, ... European journal of nuclear medicine and molecular imaging 42, 1276-1283, 2015 | 96 | 2015 |
| Chromogranin A predicts outcome in prostate cancer patients treated with abiraterone SL Burgio, V Conteduca, C Menna, E Carretta, L Rossi, E Bianchi, B Kopf, ... Endocrine-related cancer 21 (3), 487-493, 2014 | 82 | 2014 |
| PSA flare with abiraterone in patients with metastatic castration-resistant prostate cancer SL Burgio, V Conteduca, B Rudnas, F Carrozza, E Campadelli, E Bianchi, ... Clinical genitourinary cancer 13 (1), 39-43, 2015 | 81 | 2015 |
| CAR-T cell therapy: a potential new strategy against prostate cancer G Schepisi, MC Cursano, C Casadei, C Menna, A Altavilla, C Lolli, ... Journal for immunotherapy of cancer 7, 1-11, 2019 | 77 | 2019 |
| Chromogranin A is a potential prognostic marker in prostate cancer patients treated with enzalutamide V Conteduca, SL Burgio, C Menna, E Carretta, L Rossi, E Bianchi, ... The Prostate 74 (16), 1691-1696, 2014 | 77 | 2014 |
| Immunotherapy for prostate cancer: where we are headed G Schepisi, A Farolfi, V Conteduca, F Martignano, D De Lisi, G Ravaglia, ... International journal of molecular sciences 18 (12), 2627, 2017 | 52 | 2017 |
| Increased expression of 5-lipoxygenase is common in clear cell renal cell carcinoma M Faronato, G Muzzonigro, G Milanese, C Menna, AR Bonfigli, ... Histology and histopathology, 2007 | 51 | 2007 |
| Lipoxygenase inhibitors for cancer prevention: promises and risks C Menna, F Olivieri, A Catalano, A Procopio Current pharmaceutical design 16 (6), 725-733, 2010 | 45 | 2010 |
| Effects of pre‐operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study COVIDSurg Collaborative, GlobalSurg Collaborative, D Nepogodiev, ... Anaesthesia 76 (11), 1454-1464, 2021 | 42 | 2021 |
| Plasma androgen receptor and serum chromogranin A in advanced prostate cancer V Conteduca, E Scarpi, S Salvi, V Casadio, C Lolli, G Gurioli, G Schepisi, ... Scientific Reports 8 (1), 15442, 2018 | 27 | 2018 |
| Association among metabolic syndrome, inflammation, and survival in prostate cancer V Conteduca, O Caffo, L Galli, A Maugeri, E Scarpi, F Maines, VE Chiuri, ... Urologic Oncology: Seminars and Original Investigations 36 (5), 240. e1-240. e11, 2018 | 27 | 2018 |
| Testosterone levels and androgen receptor copy number variations in castration‐resistant prostate cancer treated with abiraterone or enzalutamide C Lolli, D De Lisi, V Conteduca, G Gurioli, E Scarpi, G Schepisi, ... The Prostate 79 (11), 1211-1220, 2019 | 20 | 2019 |
| Vitamin D status among long-term survivors of testicular cancer G Schepisi, S De Padova, E Scarpi, C Lolli, G Gurioli, C Menna, SL Burgio, ... Oncotarget 8 (22), 36780, 2017 | 19 | 2017 |
| Potential application of chimeric antigen receptor (CAR)-T cell therapy in renal cell tumors G Schepisi, V Conteduca, C Casadei, G Gurioli, L Rossi, V Gallà, ... Frontiers in oncology 10, 565857, 2020 | 17 | 2020 |
| Plasma androgen receptor in prostate cancer V Conteduca, G Gurioli, N Brighi, C Lolli, G Schepisi, C Casadei, ... Cancers 11 (11), 1719, 2019 | 17 | 2019 |
| Prognostic role of systemic inflammatory indexes in germ cell tumors treated with high-dose chemotherapy MC Cursano, B Kopf, E Scarpi, C Menna, C Casadei, G Schepisi, C Lolli, ... Frontiers in Oncology 10, 1325, 2020 | 15 | 2020 |
Ugo De GiorgiIstituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) - IRCCS Meldola ITALYBestätigte E-Mail-Adresse bei irst.emr.it
